A. Valipour (Wien, Austria), L. Vanfleteren (Gothenburg, Sweden), V. Andrianopoulos (Athens, Greece), J. Hurst (London, United Kingdom)
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial G. Prieur (Brussels, Belgium), C. Medrinal (Rouen, France), Y. Combret (Brussels, Belgium), E. Dupuis Lozeron (Geneva, Switzerland), T. Bonnevie (Rouen, France), F. Gravier (Rouen, France), J. Quieffin (montivilliers, France), B. Lamia (Rouen, France), J. Borel (Grenoble, France), G. Reychler (Brussels, Belgium)
| |
Application of new home oxygen therapy strategy for COPD patient in Korea : a pilot study Y. HWANG (Anyang, Republic of Korea), K. Jung (Anyang, Republic of Korea), S. Jang (Anyang, Republic of Korea), . Lim (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea)
| |
Domiciliary high-flow in patients with severe COPD and chronic hypoxic failure: In whom can we reduce exacerbations. U. Møller Weinreich (Aalborg , Denmark), L. Storgaard (Aalborg , Denmark)
| |
A patient’s perspective: The use of Oxygen Alert Wrist Bands (OxyBands) in COPD E. Rickards (Liverpool, United Kingdom), E. Mooney (Liverpool, United Kingdom), N. Glover (Liverpool, United Kingdom), O. Hampson (Liverpool, United Kingdom), D. Wat (Liverpool, United Kingdom), S. Sibley (Liverpool, United Kingdom)
| |
Performance of contemporary Portable Oxygen Concentrators across diverse breathing behaviours – A bench comparison D. Martin (Sydney, Australia), C. O' Dwyer (Dublin, Ireland)
| |
The effectiveness of PaCO2-pH coordinate plane to predict prognosis in patients with chronic respiratory failure receiving long-term oxygen therapy. T. Tsuboi (Joyo, Japan), T. Saito (Naka, Japan), S. Takata (Koga, Japan), T. Ohdaira (Niigata, Japan), S. Yano (Matsue, Japan), T. Kawamura (Himeji, Japan), T. Yamanaka (Uki, Japan), M. Abe (Toon, Japan), K. Sumi (Joyo, Japan), A. Sato (Joyo, Japan)
| |
Betablocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.4 million individuals A. Nielsen (Køge, Denmark), L. Pedersen (Aarhus, Denmark), B. Sode (Copenhagen, Denmark), M. Dahl (Køge, Denmark)
| |
Clinical characteristics of COPD patients suspected of left ventricular diastolic dysfunction S. Kim (Suwon, Republic of Korea), S. Kim (Suwon, Republic of Korea), S. Kim (Suwon, Republic of Korea), S. Song (Suwon, Republic of Korea), C. Kim (Suwon, Republic of Korea)
| |
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease. S. Ashraf (Peshawar, Pakistan), A. Ashraf (Peshawar, Pakistan)
| |
SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES. R. Sethi (YEREVAN, Armenia), H. Zakharyan (YEREVAN, Armenia), A. Muradyan (YEREVAN, Armenia)
| |
Effects of tiotropium bromide and fluticasone propionate/salmeterol on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring O. Fesenko (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), K. Bohatska (Dnipro, Ukraine)
| |
Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease V. Calancea (Chisinau, Republic of Moldova), E. Terna (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), I. Cosciug (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
| |
Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), A. Balitskaya (Yoshkar-Ola, Russian Federation), V. Elykomov (Barnaul, Russian Federation), M. Nikolaeva (Barnaul, Russian Federation), I. Sheremetyeva (Barnaul, Russian Federation)
| |
IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE) E. Ben Jemia (Ariana, Tunisia), I. Zendah (Ariana, Tunisia), C. Moussa (Ariana, Tunisia), H. Kwass (Ariana, Tunisia), H. Ghedira (Ariana, Tunisia)
| |
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), E. Blinova (Chelyabinsk, Russian Federation), I. Grebneva (Chelyabinsk, Russian Federation), O. Rodionova (Chelyabinsk, Russian Federation)
| |
Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease. V. Calancea (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), A. Cretu (Chisinau, Republic of Moldova), N. Antonova (Chisinau, Republic of Moldova), S. Oprea (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
| |
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension V. Calancea (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), D. Barba (Chisinau, Republic of Moldova), D. Fetco-Mereuta (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
| |
Late Breaking Abstract - The cost, health resources utilization and medications in chronic obstructive pulmonary patients with diabetes mellitus: a population-based cohort study in Taiwan. H. Chen (Kaohsiung city, Taiwan), W. Fang (Kaohsiung city, Taiwan), . Chen (Kaohsiung city, Taiwan), C. Lin (Kaohsiung city, Taiwan), M. Lin (Kaohsiung city, Taiwan)
| |
Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease R. Mahendran (Hatfield, United Kingdom), P. Bassin (Hatfield, United Kingdom), M. Cook (Hatfield, United Kingdom), S. Rossiter (Hatfield, United Kingdom), A. Martin (Hatfield, United Kingdom), V. Hutter (Hatfield, United Kingdom)
| |